The purpose of this study is to develop a treatment that can effectively help people reduce their alcohol use and quit smoking.
This study evaluates a mindfulness-based treatment to concurrently target cigarette smoking and alcohol use behaviors in adults. Aim 1: Modify an existing mindfulness-based treatment to include a focus on smoking cessation and reduced alcohol use. Aim 2: Evaluate benchmarks regarding the feasibility and acceptability of Mindfulness Based Relapse Prevention -Smoking and Alcohol Use. Aim 3: Collect and examine descriptive data on proximal and distal variables associated with increased smoking abstinence and reduced drinking.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
67
Mindfulness Based Relapse Prevention (MBRP) is a treatment for preventing relapse in addictive disorders that integrates mindfulness meditation with standard relapse prevention practices.
Cognitive Behavioral Therapy (CBT) is a form of therapy that aims to help individuals modify problematic emotions, behaviors, and thoughts.
H Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
Aim 2: Number of Participants Scoring >3
Number of participants scoring \>3. Patient satisfaction will be determined through a score on the Client Satisfaction Questionnaire Version 8 (Attkinson \& Greenfield), where participants respond to 8 items on a 4-point scale (1=very dissatisfied; 4=very satisfied). Results reported indicate clients with a patient satisfaction score over 80%.
Time frame: End of Treatment at 8 Weeks
Aim 2: Rate of Recruitment of Eligible Participants
Rate of recruitment was measured by calculating the average of eligible participants who were recruited per week
Time frame: 20 weeks
Aim 2: Participant Retention
Percentage of participants retained through follow-up
Time frame: End of study at Week 16 Follow-up
Aim 2: Percentage of Participants That Completed Questionnaires
Percentage of participants who completed questionnaires at week 16
Time frame: End of study at Week 16 Follow-up
Aim 3: Percent of Smoking Abstinence End of Treatment
Participants will self-report of no smoking in the last 7 days using the 7-day point prevalence.
Time frame: End of Treatment at 8 Weeks
Aim 3: Percent of Smoking Abstinence at 16 Week Follow-up
Percent of smoking abstinence, measured by biochemical verification of abstinence via saliva continine and self-report of no smoking in the past 7 days. Participants who report abstinence will be mailed a saliva continine kit to confirm abstinence at their 16 week follow up call.
Time frame: At 16 week follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Aim 3: Percent of Heavy Alcohol Use at End of Treatment
Percent of heavy drinking days during the prior week. Heavy drinking is defined as greater or equal to 4 drinks per day for women and greater or equal to 5 drinks per day for men.
Time frame: End of Treatment at 8 Weeks
Aim 3: Percentage of Heavy Alcohol Use at 16 Week Follow-up
Percent of heavy drinking days during the prior week. Heavy drinking is defined as greater or equal to 4 drinks per day for women and greater or equal to 5 drinks per day for men.
Time frame: At 16 week follow-up